Risk Of Developing Multiple Sclerosis Significantly Reduced With Interferon Beta-1b Early Treatment

... Researchers have found that treatmentof patients with interferon beta-1b after a first attack suggestive ofmultiple sclerosis (MS) cuts their risk of developing the disease in halfover the next two years, according to results from the BENEFIT(BEtaferon(R)/BEtaseron(R) in Newly Emerging Multiple Sclerosis for InitialTreatment) clinical trial. [click link for full article] ...